Tiagabine

Seminars in Pediatric Neurology

Volumn 4, Issue 1, 1997, Pages 24-33

  Shinnar, S ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CIMETIDINE; DIGOXIN; ORAL CONTRACEPTIVE AGENT; PHENOBARBITAL; PHENYTOIN; PLACEBO; PRIMIDONE; THEOPHYLLINE; TIAGABINE; VALPROIC ACID; WARFARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHENIA; ATAXIA; CLINICAL TRIAL; DEPRESSION; DIARRHEA; DRUG MECHANISM; EPILEPSY; HUMAN; HUMAN EXPERIMENT; NONHUMAN; NORMAL HUMAN; PHARMACOKINETICS; SOMNOLENCE; TREMOR; VERTIGO;

EID: 0030934967     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9091(97)80006-X     Document Type: Article

References (57)

1. Dichter MA Brodie MJ New antiepileptic drugs N Engl J Med 334 1996 1583 1590
2. Wyllie E New developments in antiepileptic drug therapy Epilepsia 36 suppl 2 1995 S1 S118
3. Suzdak PD Jansen JA A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor Epilepsia 36 1995 612 626
4. Meldrum B Pharmacology of GABA Clin Neuropharmacol 5 1982 293 316
5. MacDonald RL Kelly KM Antiepileptic drug mechanisms of action Epilepsia 36 suppl 2 1995 S2 S12
6. Farriello RG Varasi M Smith MC Valproic Acid: mechanisms of action Levy RH Mattson RH Meldrum BS Antiepileptic Drugs fourth edition 1995 Raven New York, NY 581 588
7. Ben-Menachem E Vigabatrin Epilepsia 36 suppl 2 1995 S95 S104
8. Giardina WJ Anticonvulsant action of tiagabine, a new GABA-uptake inhibitor J Epilepsy 7 1994 161 166
9. Ostergaard LH Gram L Dam M Potential antiepileptic drugs: tiagabine Levy RH Mattson RH Meldrum BS Antiepileptic Drugs fourth edition 1995 Raven New York, NY 1057 1061
10. Mengel HB Tiagabine Epilepsia 35 suppl 5 1994 S81 S84
11. Nielsen EB Suzdac PD Andersen KE Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor Eur J Pharmacol 196 1991 257 266
12. Andersen KE Braestrop C Gronwald FC The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2thienyl)-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidate J Med Chem 36 1993 1716 1725
13. Thompson SM Gahwiler BH Effects of the GABA uptake inhibitor tiagabine on inhibitory synaptic potentials in rat hippocampal slice cultures J Neurophsiol 67 1992 1698 1701
14. Richens A Chadwick D Duncan J Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled study Epilepsy Res 21 1995 37 42
15. Rowan AJ Uthman B Ahmann P Safety and efficacy of three dose levels of tiagabine HCl versus placebo as adjunctive treatment for complex partial seizures Epilepsia 35 suppl 8 1994 54
16. Sachdeo R Leroy R Krauss G Safety and efficacy of BID and QID dosing with tiagabine HCl versus placebo as adjunctive treatment for partial seizures Neurology 45 suppl 4 1995 A202
17. Leppik I Sachdeo RC Schachter S Long-term safety of tiagabine HCl Epilepsia 35 suppl 8 1994 144
18. Kalviainen R Aikia M Saukkonen AM Cognitive effects of tiagabine Epilepsia 35 suppl 7 1994 74
19. Arnett JL Dodrill CB Mercante DE Evaluation of effects of tiagabine on cognitive functioning and adjustment in patients with epilepsy Epilepsia 36 suppl 4 1995 55
20. Gustavson LE Guenther HJ Boellner SW A single dose study to define the pharmacokinetics of tiagabine in pediatric patients Neurology 46 2 1996 A176
21. Uldall P Bulteau C Pederson SA Single-blind study of safety, tolerability, and preliminary efficacy of tiagabine as adjunctive treatment of children with epilepsy Epilepsia 36 suppl 3 1995 S147
22. Boellner SW McCarty J Mercante D Pilot study of tiagabine in children with partial seizures Epilepsia 37 suppl 4 1996 92
23. Croucher MJ Meldrum BS Krogsgaard-Larsen P Anticonvulsant activity of GABA uptake inhibitors and their prodrugs following central or systemic administration Euro J Pharmacol 89 1983 217 228
24. Rekling JC Jahnsen H Laursen AM The effect of two lipophilic gamma-aminobutyric acid uptake blockers in CA1 of the rat hippocampal slice Br J Pharmacol 99 1990 103 106
25. Braestrup C Nielsen EB Sonnewald U (R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid binds with high affinity to the brain gamma-aminobutyric acid uptake carrier J Neurochem 54 1990 639 647
26. Borden LA Murali Dhar TG Smith KE Tiagabine, SKF 89976-A, CI-966 and NNC-711 are selective for the cloned GABA transporter GAT-1 Eur J Pharmacol 269 1994 2219 2224
27. Bopp BA Nequist GE Rodrigues AD Role of the cytochrome P450 3A subfamily in the metabolism of [14C] tiagabine in human hepatic microsomes Epilepsia 36 suppl 3 1995 S159
28. Gustavson LE Mengel HB Pharmacokinetics of tiagabine, a gamma-aminobutyric acid-uptake inhibitor, in healthy subjects after single and multiple doses Epilepsia 36 6 1995 605 611
29. Mengel HB Gustavson LE Soerensen HJ Effect of food on the bioavailability of tiagabine HCl Epilepsia 32 suppl 3 1991 6
30. Richens A Gustavson LE McKelvy JF Pharmacokinetics and safety of single-dose tiagabine HCl in epileptic patients chronically treated with four other antiepileptic drug regimens Epilepsia 32 suppl 3 1991 12
31. Mengel HB Houston A Back DJ An evaluation of the interaction between tiagabine and oral contraceptives in female volunteers J Pharm Med 4 1994 141 150
32. Gustavson LE Mengel HB Pierce MW Tiagabine, a new gamma-aminobutyric acid uptake inhibitor antiepileptic drug: pharmacokinetics after single oral doses in man Epilepsia 31 1990 642
33. Mengel HB Pierce M Mant T Tiagabine, a GABA-uptake inhibitor: safety and tolerance of multiple dosing in normal subjects Acta Neurol Scand 82 suppl 133 1990 35
34. 14C-tiagabine in humans Epilepsia 33 suppl 3 1992 83
35. During M Mattson R Scheyer R The effect of tiagabine HCl on extracellular GABA levels in the human hippocampus Epilepsia 33 suppl 3 1992 83
36. So EL Wolff D Graves NM Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing drugs Epilepsy Res 22 1995 221 226
37. Cato A Qian JX Gustavson LE Pharmacokinetics and safety of tiagabine in subjects with various degrees of renal function Epilepsia 36 suppl 3 1995 S159
38. Gustavson LE Qian JX Saulis R Pharmacokinetics and safety of tiagabine in subjects with varying degrees of hepatic function Epilepsia 36 suppl 3 1995 S159
39. Suzdak PD Lipophilic GABA uptake inhibitors: biochemistry, pharmacology, and therapeutic potential Drugs of the Future 18 1993 1129 1136
40. Walton NY Gunawan S Treiman DM Treatment of experimental status epilepticus with the GAB uptake inhibitor, tiagabine Epilepsy Res 19 1994 237 244
41. Coenen AM Blezer EH van Luijtelaar EL Effects of the GABA uptake inhibitor tiagabine on electroencephalogram, spike-wave discharges and behaviour of rats Epilepsy Res 21 1995 89 94
42. Velisek L Veliskova J Ptachewich Y Effects of MK-801 and phenytoin on flurothyl-induced seizures during development Epilepsia 36 1995 179 185
43. Velisek L Veliskova J Ptachewich Y Agedependent effects of gamma-aminobutyric acid agents on flurothyl seizures Epilepsia 36 1995 636 643
44. Sheridan PH Jacobs MP Conference Review. The development of antiepileptic drugs for children: Report from the NIH workshop Bethesda, MD, February 17–18, 1994 Epilepsy Res 23 1996 87 92
45. Schachter SC Sommerville KW Tiagabine: A potent new drug for partial seizures Presented at Third Eilat conference on new antiepileptic drugs Eilat, Israel May 28–29, 1996
46. Schachter SC Tiagabine monotherapy in the treatment of partial epilepsy Epilepsia 36 suppl 6 1995 S2 S6
47. Alarcon G Binnie CD Elwes RDC Monotherapy antiepileptic drug trials in patients undergoing presurgical assessment: Methodological problems and possibilities Seizure 4 1995 293 301
48. Pierce MW Suzdak PD Andersen KE Tiagabine Pisani F Perucca E Avansini A New Antiepileptic Drugs 1991 Elsevier Amsterdam, The Netherlands 157 160
49. Mengel HB Mant TGK McKelvy JM Tiagabine: Phase I study of safety and tolerance following single oral doses Epilepsia 31 5 1990 642
50. Leach JP Stolarek I Brodie MJ Deliberate overdose with the novel anticonvulsant tiagabine Seizure 4 1995 155 157
51. Brodie MJ Tiagabine pharmacology in profile Epilepsia 36 suppl 6 1995 S7 S9
52. Messenheimer JA Lamotrigine Epilepsia 36 suppl 2 1995 S87 S94
53. Yuen AWC Lamotigine: Interaction with other drugs Levy RH Mattson RH Meldrum BS Antiepileptic Drugs fourth edition 1995 Raven New York, NY 883 888
54. Dodson WE Principles of antiepileptic drug therapy Shinnar S Amir N Branski D Childhood Seizures 1995 S Karger Basel, Switzerland 78 92
55. Gustavson LE Cato A Guenther HJ Lack of clinically important drug interactions between tiagabine and carbamazepine, phenytoin or valproate Epilepsia 36 suppl 3 1995 S159
56. Mengel HB Jansen JA Sommerville K Tiagabine: evaluation of the risk of interaction with theophylline, warfarin, digoxin, cimetidine, oral contraceptives, triazolam, or ethanol Epilepsia 36 suppl 3 1995 S160
57. Leppik IE Felbamate Epilepsia 36 suppl 2 1995 S66 S72